Is Summit Therapeutics PLC (SMMT) A Good Stock To Buy?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Summit Therapeutics Inc. (SMMT)
Get Email AlertsHedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Polar Capital Brian Ashford-Russell And Tim Woolley | 0 | $0 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
| 3. | Lansdowne Partners Alex Snow | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.24 | 11,365,921 | Large Shareholder, Officer, Director | 67,662,454 | 2021-05-12 | Filing | |
| $5.24 | 389,077 | Officer, Director | 2,643,319 | 2021-05-12 | Filing | |
| $3.34 | 14,071,856 | Large Shareholder, Officer, Director | 56,296,533 | 2020-11-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.44 | 13,713 | Officer | 0 | 2020-11-30 | Filing | |
| $4.39 | 29,569 | Officer | 0 | 2020-11-27 | Filing | |
| $4.32 | 12,070 | Officer | 0 | 2020-11-25 | Filing | |
| $4.21 | 11,374 | Officer | 0 | 2020-11-24 | Filing | |
| $4.40 | 6,987 | Officer | 0 | 2020-11-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 11,245 | $28 | 0% | |
| 2. | 2,000 | $5 | 0% | |
| 3. | 1,000 | $1 | 0% | |
| 4. | 36 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
13D Filing: Lansdowne Partners and Summit Therapeutics PLC (ADR) (SMMT)
Summit Therapeutics PLC (ADR) (NASDAQ:SMMT): Alex Snow's Lansdowne Partners filed an amended 13D.
You can check out Lansdowne Partners' latest holdings and filings here.
Market Movers Today: Iovance Biotherapeutics Inc (IOVA), Key Technology, Inc. (KTEC), Union Pacific Corporation (UNP), and More
What happened: Shares of pre-revenue biopharma Iovance Biotherapeutics (NASDAQ:IOVA) rose nearly 30% today after the company announced preliminary results from two phase 2 trials evaluating one of its...
13D Filing: Lansdowne Partners and Summit Therapeutics PLC (ADR) (SMMT)
Summit Therapeutics PLC (ADR) (NASDAQ:SMMT): Alex Snow's Lansdowne Partners filed an amended 13D.
You can check out Lansdowne Partners' latest holdings and filings here.
What We’re Looking For From Summit Therapeutics PLC (ADR) (SMMT)
Summit Therapeutics PLC (ADR) (NASDAQ:SMMT) is running up this week on an update relating to its lead C. Difficile infection asset, Ridinilazole.
Delta Air Lines Inc. (DAL), Summit Therapeutics PLC (ADR) (SMMT) & More: A Look at Five Stocks on the Move Today
Markets have opened at shaky note with major indices treading on margin.
Summit Therapeutics PLC (ADR) (SMMT) Is Hot On Sarepta Therapeutics Inc (SRPT)’s DMD Tail
Duchenne’s Muscular Dystrophy (DMD) is a hot topic right now.
Hedge Fund Sentiment Is Stagnant On Summit Therapeutics PLC (ADR) (SMMT)
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies.
Billionaire Hedge Funds
